Hydration breaks at the 2026 World Cup and a broader push for wellbeing in offices are shining a fresh spotlight on consumer health and wellness products, from bottled water to branded drinkware. For investors, that is less about sports headlines and more about which stocks are meaningfully exposed to this surge in attention on hydration, premium beverages, and workplace wellness. This article walks through three stocks from our Consumer Health & Wellness Products screener that appear positioned to benefit from these trends and explains how the same themes could help you decide which opportunities to lean into or avoid.

Buda Juice (BUDA)

Overview: Buda Juice is a Dallas based beverage company that produces and distributes clean label citrus juices, cold pressed fruit and vegetable juices, lemonades, limeades, and wellness shots to wholesale customers across the United States.

Operations: The company generates all of its US$13.1 million in revenue from cold crafted citrus based beverages sold in the United States.

Market Cap: US$118.0 million

Buda Juice gives you direct exposure to the push for premium hydration, with all of its revenue tied to cold crafted citrus drinks and fresh distribution momentum such as Buda Fresh Cherry Limeade reaching 246 Walmart stores across nine states. Revenue grew 14.7% year on year and analysts expect strong double digit growth in both revenue and earnings. The stock trades on a P/E of 37.9x and above an estimated cash flow value, so expectations are already high. Net profit margin has slipped from 30.8% to 23.7%, the board is relatively new, and the company relies entirely on external borrowing, which adds funding risk. Investors who are comfortable with those trade offs may still see the hydration trend as a potential tailwind for Buda Juice.

Buda Juice’s premium hydration story is accelerating, yet a 37.9x P/E and reliance on borrowing raise questions that headlines miss. Get the full context in the analysis report for Buda Juice

Thorne HealthTech (THRN)

Overview: Thorne HealthTech is a science based wellness company that sells at home health tests, personalized nutrition supplements, and education tools that help people track sleep, stress, gut health, aging, and other metrics so they can manage their wellbeing more proactively.

Operations: Thorne HealthTech generates about US$258.0 million in revenue from selling personalized health and wellness solutions, with roughly US$236.9 million from the United States and US$21.1 million from international markets.

Market Cap: US$550.6 million

Thorne HealthTech is closely aligned with the wellness and hydration focus now being pushed on the sports field and into offices. Its earnings and revenue growth forecasts suggest the business is scaling around that demand. The stock screens as materially below an estimated fair value while still carrying a relatively high P/E, which points to a mix of growth expectations and potential valuation considerations that many investors may want to understand more clearly. Improving margins and a long standing management team sit alongside real risks, including recent shareholder dilution, share price volatility, and reliance on external borrowing. For anyone tracking the wellness and hydration theme, the question is whether those trade offs are a fair price for Thorne’s current position.

Thorne HealthTech’s mix of growth expectations and a high P/E suggests the market might be missing something in the company’s risk and reward balance, and the 3 key rewards and 3 important warning signs (1 is major!) could be where that tension really shows.

Celsius Holdings (CELH)

Overview: Celsius Holdings is a Boca Raton based beverage company that develops, manufactures, and sells functional energy and zero sugar hydration drinks, powders, and wellness products under the CELSIUS, Alani Nu, and Rockstar brands across retail stores, gyms, and e commerce channels globally.

Operations: Celsius Holdings generates about US$3.0b in revenue from non alcoholic beverages, with roughly US$2.9b from North America and the balance from Europe, Asia Pacific, and other markets.

Market Cap: US$7.6b

Celsius Holdings is positioned at the intersection of the World Cup style hydration push and everyday wellness, selling sugar free functional energy and hydration products that align with more frequent breaks on the field and in the office. Earnings have grown faster than the broader beverage industry and are forecast to grow above 20% a year, yet recent one off losses of US$421.3m, a thin 3.9% net margin, and reliance on higher risk external borrowing show how dependent the current 66.6x P/E is on strong execution from the Celsius, Alani Nu, and Rockstar portfolio. For investors, the key issue is whether that mix of growth potential, funding risk, and premium valuation still appears attractive once you examine the details.

Accelerating revenue, a thin 3.9% margin, and a 66.6x P/E suggest investors may not be seeing the full Celsius Holdings story. Before you decide what that means for you, review the analyst forecasts for Celsius Holdings

The three stocks covered here are only the start, with the full Consumer Health & Wellness Products screen surfacing 16 more companies that tie hydration, wellness, and beverage themes into equally compelling business stories through the Consumer Health & Wellness Products screener. Use Simply Wall St to identify and analyze the exact catalysts, financial traits, and narratives that matter to you so you can focus on the highest conviction opportunities in this space.

Take Control of Your Investment Journey

If Celsius Holdings or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before Others Do?

New ideas can move fast, and once momentum builds the best entry points can slip away. Scan these fresh stock pools while they are still under the radar and consider acting before conditions change.

• Target steady income potential before yields get compressed by latecomers with a curated set of 8 dividend fortresses that focus on resilience and cash return strength.
• Explore the next wave of cryptofocused businesses before interest shifts by checking curated 19 cryptocurrency and blockchain stocks built around real operating traction, not hype.
• Identify underfollowed operators in critical metals before demand stories change by screening the 30 best rare earth metal stocks curated for balance sheet strength and production focus.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.